2CARE4 ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  2.0% 2.4% 6.7% 1.0% 1.0%  
Credit score (0-100)  70 64 34 86 85  
Credit rating  A BBB BBB A A  
Credit limit (mDKK)  0.0 0.0 0.0 7.1 9.3  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (mDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  830 864 830 1,164 1,206  
Gross profit  96.1 85.2 53.3 124 162  
EBITDA  22.8 9.5 -23.3 63.6 83.8  
EBIT  22.8 9.5 -23.3 52.5 75.4  
Pre-tax profit (PTP)  15.8 4.1 -21.3 43.3 62.8  
Net earnings  15.8 4.1 -21.3 33.7 48.8  
Pre-tax profit without non-rec. items  22.8 9.5 -23.3 43.3 62.8  

 
See the entire income statement

Balance sheet (mDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 3.3 4.9  
Shareholders equity total  58.7 62.7 41.5 75.1 105  
Interest-bearing liabilities  0.0 0.0 0.0 300 241  
Balance sheet total (assets)  342 331 382 442 447  

Net Debt  0.0 0.0 0.0 293 239  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  830 864 830 1,164 1,206  
Net sales growth  8.3% 4.1% -4.0% 40.2% 3.6%  
Gross profit  96.1 85.2 53.3 124 162  
Gross profit growth  5.6% -11.3% -37.5% 132.9% 30.8%  
Employees  102 118 108 110 131  
Employee growth %  29.1% 15.7% -8.5% 1.9% 19.1%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  342 331 382 442 447  
Balance sheet change%  8.5% -3.0% 15.5% 15.6% 1.1%  
Added value  22.8 9.5 -23.3 52.5 83.8  
Added value %  2.7% 1.1% -2.8% 4.5% 6.9%  
Investments  -19 0 0 6 -1  

Net sales trend  3.0 4.0 -1.0 1.0 2.0  
EBIT trend  4.0 5.0 -1.0 1.0 2.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  2.7% 1.1% -2.8% 5.5% 6.9%  
EBIT %  2.7% 1.1% -2.8% 4.5% 6.3%  
EBIT to gross profit (%)  23.7% 11.1% -43.7% 42.3% 46.4%  
Net Earnings %  1.9% 0.5% -2.6% 2.9% 4.1%  
Profit before depreciation and extraordinary items %  1.9% 0.5% -2.6% 3.8% 4.7%  
Pre tax profit less extraordinaries %  2.7% 1.1% -2.8% 3.7% 5.2%  
ROA %  6.9% 2.8% -6.5% 13.2% 18.2%  
ROI %  7.7% 2.8% -6.5% 12.3% 15.3%  
ROE %  31.2% 6.7% -40.8% 57.7% 54.3%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  100.0% 100.0% 100.0% 23.0% 39.8%  
Relative indebtedness %  0.0% 0.0% 0.0% 20.2% 11.7%  
Relative net indebtedness %  0.0% 0.0% 0.0% 19.5% 11.6%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% 0.0% 460.2% 285.7%  
Gearing %  0.0% 0.0% 0.0% 399.8% 229.7%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 7.5% 6.7%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.0 0.0 0.0 1.2 1.6  
Current Ratio  0.0 0.0 0.0 2.0 3.0  
Cash and cash equivalent  0.0 0.0 0.0 7.9 1.2  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 45.3 47.3  
Trade creditors turnover (days)  0.0 0.0 0.0 4.1 13.1  
Current assets / Net sales %  0.0% 0.0% 0.0% 36.5% 35.0%  
Net working capital  0.0 0.0 0.0 207.6 281.7  
Net working capital %  0.0% 0.0% 0.0% 17.8% 23.4%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  8 7 8 11 9  
Added value / employee  0 0 -0 0 1  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 -0 1 1  
EBIT / employee  0 0 -0 0 1  
Net earnings / employee  0 0 -0 0 0